Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07604051Phase 4Completed

Termination of Pregnancy in Previous Scarred Uterus: PGE1 Versus Cervical Folleys

Role: lead

NCT07601035Not ApplicableCompleted

Transumbilical Versus Infraumbilical Pneumoperitoneum in Laparoscopic Cholecystectomy

Role: lead

NCT07582471Not ApplicableCompleted

Insulin Versus Oral Hypoglycemic Agents in Gestational Diabetes Mellitus

Role: lead

NCT07586371Phase 2Active Not Recruiting

Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i

Role: lead

All 4 trials loaded